Page last updated: 2024-08-17

levodopa and Atrophy

levodopa has been researched along with Atrophy in 61 studies

Research

Studies (61)

TimeframeStudies, this research(%)All Research%
pre-199015 (24.59)18.7374
1990's21 (34.43)18.2507
2000's10 (16.39)29.6817
2010's10 (16.39)24.3611
2020's5 (8.20)2.80

Authors

AuthorsStudies
Adachi, T; Hanajima, R; Hasegawa, M; Sakata, R; Sakuwa, M; Suzuki, Y; Takigawa, H1
Fasano, A; Gorodetsky, C; Lang, AE; Lozano, AM; Youn, J1
Chelban, V; Cortese, A; Houlden, H; O'Connor, E; Rossi, S; Sullivan, R; Wood, NW; Yau, WY1
Chung, SJ1
Bocci, T; Bongioanni, P; Orlandi, G; Santin, M; Sartucci, F1
Giladi, N; Hausdorff, JM; Hendler, T; Herman, T; Jacob, Y; Rosenberg-Katz, K1
Barone, P; Bovi, T; Censi, D; Fasano, A; Juergenson, I; Montemezzi, S; Squintani, G; Tinazzi, M; Vattemi, G1
Miletić, V; Ozretić, D; Relja, M1
Camicioli, R; Emery, D; Gee, M; Sabino, J; Sapkota, S1
Costello, D; Lynch, T; McCarthy, A; Mulroy, E; Ross, OA1
D'Abreu, A; França, MC; Friedman, JH; Lopes-Cendes, I; Martinez, AR; Nunes, MB; Rezende, TJ1
Goto, Y; Isozaki, E; Sunami, Y; Warabi, Y1
Adam, OR; Ferrara, JM; Ondo, WG1
Damon-Perrière, N; Meissner, WG; Tison, F1
Arami, MA; Ayromlou, H; Najmi, S1
Chang, HC; Chen, RS; Lu, CS; Tsai, CH; Wu Chou, YH; Yen, TC1
Bakay, RA; Barnhart, H; Chockkan, V; DeLong, MR; Evatt, M; Freeman, A; Green, J; Haber, M; McDonald, W; Mewes, K; Triche, S; Vitek, JL; Wahlay, N; Zhang, JY1
Apetauerova, D; Norregaard, T; Ryan, P; Tarsy, D1
Berciano, J; Combarros, O; Corral, J; Infante, J; Pascual, J; Polo, JM; Volpini, V1
Funakawa, I; Katayama, S; Konishi, Y; Shirabe, T; Terao, A1
Balci, K; Celik, Y; Kabayel, L; Turgut, N1
Haginoya, K; Higano, S; Iinuma, K; Ishitobi, M; Kitamura, T; Nara, T; Onuma, A; Togashi, N; Wakusawa, K; Yokoyama, H1
Mercimek-Mahmutoglu, S; Stockler-Ipsiroglu, S1
Bargalló, N; Giménez, M; Junqué, C; Martí, MJ; Ramírez-Ruiz, B; Tolosa, E; Valldeoriola, F1
He, QJ; Xu, SQ1
Mayeux, R; Stern, Y1
Goetz, CG; Klawans, HL; Tanner, CM1
Goldman, JW; Haldeman, S; Hyde, J; Pribram, HF1
Ciannella, L; Dell'Aria, V; Melone, MA2
Angelini, L; Broggi, G; Mainini, P; Moretti, G; Nardocci, N1
Duvoisin, RC; Mark, MH; Miller, DC; Sage, JI; Walters, AS1
Bressi, S; Caraceni, T; Cortelli, P; Fazio, F; Gentrini, S; Grassi, F; Perani, D; Savoiardo, M; Testa, D1
Golbe, LI; Goodman, JC; Jankovic, J; Rajput, AH1
Fénelon, G; Feve, A; Guillard, A; Mahieux, F; Romatet, S1
Churchyard, A; Donnan, GA; Howells, DW; Hughes, A; Kalnins, RM; Mendelsohn, FA; Paxinos, G; Wong, JY; Woodhouse, D1
Bergmans, PL; Konings, CH; Kuiper, MA; Wolters, EC1
Benhadjali, J; Bughin, M; Delalande, I; Destée, A; Forzy, G; Hache, JC1
Albanese, A; Colosimo, C; Lees, AJ; Tonali, P1
Cooper, JM; Daniel, SE; Gash, MT; Gu, M; Marsden, CD; Quinn, NP; Schapira, AH; Wenning, GK1
Caraceni, T; Fetoni, V; Genitrini, S; Girotti, F; Monza, D; Soliveri, P; Testa, D1
Kimber, JR; Mathias, CJ; Watson, L1
Arnold, G; Gasser, T; Oertel, WH; Schwarz, J; Tatsch, K1
De Mari, M; Federico, F; Giannini, P; Iliceto, G; Lamberti, P; Lucivero, V; Mezzapesa, DM; Simone, IL; Tarantino, A1
Pearce, JM1
Becker, H; Beyer, M; Fischer, PA; Jacobi, P; Schneider, E1
Becker, H; Fischer, PA; Hacker, H; Jacobi, P; Schneider, E1
Hoehn, MM; Kelts, KA1
Burguera, JA; Carrera, N; Delgado, G; Marti Massó, JF; Martínez Lage, JM1
Coper, H; Hausmanowa-Petrusewicz, I; Kaminska, A; Ossowska, K; Schulze, G; Wolfarth, S1
Colosimo, C; Daniel, SE; Hughes, AJ; Kleedorfer, B; Lees, AJ1
Dubas, F; Henin, D; Vidailhet, M1
Marsden, CD; Pires, M; Quinn, NP; Scaravilli, F; Steiger, MJ1
Ardouin, C; Crouzet, G; Durif, F; Hommel, M; Le Bas, JF; Perret, J; Pollak, P1
Court, J; Godoy, J; Valenzuela, R1
Caraceni, T1
Burke, RE; Fahn, S; Giladi, N; Gordon, M; Hunt, A; Kostic, V; Przedborski, S1
Harvey, NS1
Adam, MJ; Ammann, W; Beattie, BL; Calne, DB; Harrop, R; Kamo, H; Li, DK; McGeer, EG; McGeer, PL; Tuokko, H1
Artieda, J; Luquin, MR; Martínez Lage, JM; Obeso, JA; Tuñón, T1

Reviews

5 review(s) available for levodopa and Atrophy

ArticleYear
[Multiple system atrophy].
    Psychologie & neuropsychiatrie du vieillissement, 2010, Volume: 8, Issue:3

    Topics: Aged; Antiparkinson Agents; Atrophy; Brain; Combined Modality Therapy; Cross-Sectional Studies; Humans; Levodopa; Magnetic Resonance Imaging; Multiple System Atrophy; Neurologic Examination; Palliative Care; Parkinsonian Disorders; Physical Therapy Modalities; Prognosis; Survival Rate

2010
Intellectual dysfunction and dementia in Parkinson disease.
    Advances in neurology, 1983, Volume: 38

    Topics: Aged; Atrophy; Basal Ganglia; Cerebral Cortex; Dementia; Humans; Intelligence; Levodopa; Middle Aged; Parkinson Disease; Psychological Tests

1983
Aetiology and natural history of Parkinson's disease.
    British medical journal, 1978, Dec-16, Volume: 2, Issue:6153

    Topics: Aged; Atrophy; Brain; Dopamine; Female; Humans; Levodopa; Male; Middle Aged; Neurotransmitter Agents; Parkinson Disease; Prognosis; Substantia Nigra

1978
Psychiatric disorders in parkinsonism: 2. Organic cerebral states and drug reactions.
    Psychosomatics, 1986, Volume: 27, Issue:3

    Topics: Amantadine; Antiparkinson Agents; Atrophy; Brain; Bromocriptine; Cognition; Dementia; Dreams; Drug Interactions; Ergolines; Humans; Levodopa; Libido; Memory; Parasympatholytics; Parkinson Disease; Receptors, Dopamine; Sexual Behavior; Substance-Related Disorders; Visual Perception

1986
Positron emission tomography in patients with clinically diagnosed Alzheimer's disease.
    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 1986, Mar-15, Volume: 134, Issue:6

    Topics: Aged; Alzheimer Disease; Atrophy; Cerebellar Cortex; Cerebral Cortex; Deoxyglucose; Female; Fluorodeoxyglucose F18; Glucose; Humans; Levodopa; Magnetic Resonance Spectroscopy; Male; Middle Aged; Oxygen; Psychological Tests; Radioisotopes; Tomography, Emission-Computed; Tomography, X-Ray Computed; Water

1986

Trials

5 trial(s) available for levodopa and Atrophy

ArticleYear
Dystonia in Machado-Joseph disease: Clinical profile, therapy and anatomical basis.
    Parkinsonism & related disorders, 2015, Volume: 21, Issue:12

    Topics: Adult; Ataxin-3; Atrophy; Botulinum Toxins, Type A; Brain; Diffusion Tensor Imaging; Dystonic Disorders; Female; Gray Matter; Humans; Levodopa; Machado-Joseph Disease; Magnetic Resonance Imaging; Male; Middle Aged; Motor Cortex; Repressor Proteins; Severity of Illness Index; Single-Blind Method; Thalamus; Trinucleotide Repeats; Videotape Recording; White Matter

2015
Randomized trial of pallidotomy versus medical therapy for Parkinson's disease.
    Annals of neurology, 2003, Volume: 53, Issue:5

    Topics: Antiparkinson Agents; Atrophy; Brain; Carbidopa; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Drug Combinations; Dyskinesia, Drug-Induced; Female; Follow-Up Studies; Globus Pallidus; Humans; Hypokinesia; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Muscle Rigidity; Neurosurgical Procedures; Parkinson Disease; Severity of Illness Index; Treatment Outcome; Tremor

2003
Visual evoked potentials and spatiotemporal contrast sensitivity changes in idiopathic Parkinson's disease and multiple system atrophy.
    Advances in neurology, 1996, Volume: 69

    Topics: Aged; Antiparkinson Agents; Atrophy; Contrast Sensitivity; Evoked Potentials, Visual; Female; Humans; Levodopa; Male; Middle Aged; Motion Perception; Movement; Nervous System Diseases; Parkinson Disease; Space Perception; Time Perception; Vision, Monocular

1996
The clinical diagnosis of multiple system atrophy presenting as pure parkinsonism.
    Advances in neurology, 1996, Volume: 69

    Topics: Aged; Antiparkinson Agents; Atrophy; Autonomic Nervous System; Brain; Dopamine Agents; Humans; Levodopa; Magnetic Resonance Imaging; Middle Aged; Nervous System Diseases; Parkinson Disease; Prospective Studies; Retrospective Studies

1996
[123]IBZM binding predicts dopaminergic responsiveness in patients with parkinsonism and previous dopaminomimetic therapy.
    Movement disorders : official journal of the Movement Disorder Society, 1997, Volume: 12, Issue:6

    Topics: Adult; Aged; Apomorphine; Atrophy; Benzamides; Binding Sites; Cerebral Cortex; Dopamine; Dopamine Agonists; Dopamine Antagonists; Follow-Up Studies; Humans; Levodopa; Magnetic Resonance Imaging; Middle Aged; Parkinson Disease; Predictive Value of Tests; Putamen; Pyrrolidines; Receptors, Dopamine D2; Tomography, Emission-Computed, Single-Photon

1997

Other Studies

51 other study(ies) available for levodopa and Atrophy

ArticleYear
An autopsy case of progressive supranuclear palsy. Pallido-nigro-luysian type with argyrophilic grains clinically presenting with personality and behavioral changes.
    Neuropathology : official journal of the Japanese Society of Neuropathology, 2022, Volume: 42, Issue:5

    Topics: Aged; Aged, 80 and over; Atrophy; Autopsy; Humans; Levodopa; Male; Neurodegenerative Diseases; Personality; Supranuclear Palsy, Progressive; tau Proteins

2022
Hemiatrophy-hemiparkinsonism and Poland syndrome: A causative or coincidental association?
    Parkinsonism & related disorders, 2023, Volume: 110

    Topics: Atrophy; Humans; Levodopa; Parkinson Disease; Parkinsonian Disorders; Poland Syndrome

2023
Dopa-Responsive Parkinsonism in a Patient With Homozygous RFC1 Expansions.
    Movement disorders : official journal of the Movement Disorder Society, 2020, Volume: 35, Issue:10

    Topics: Atrophy; Humans; Levodopa; Multiple System Atrophy; Parkinsonian Disorders

2020
Subcortical and brainstem hemiatrophy accompanied by iron deposition in a patient with hemiparkinsonism-hemiatrophy syndrome: a case report.
    BMC neurology, 2021, Feb-03, Volume: 21, Issue:1

    Topics: Antiparkinson Agents; Atrophy; Brain; Functional Laterality; Humans; Iron; Levodopa; Magnetic Resonance Imaging; Male; Parkinsonian Disorders; Young Adult

2021
High-resolution ultrasound changes of the vagus nerve in idiopathic Parkinson's disease (IPD): a possible additional index of disease.
    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2021, Volume: 42, Issue:12

    Topics: Aged; Aged, 80 and over; Atrophy; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Ultrasonography; Vagus Nerve

2021
Gray matter atrophy distinguishes between Parkinson disease motor subtypes.
    Neurology, 2013, Apr-16, Volume: 80, Issue:16

    Topics: Aged; Antiparkinson Agents; Atrophy; Brain; Cognition; Data Interpretation, Statistical; Female; Gait Disorders, Neurologic; Humans; Image Processing, Computer-Assisted; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Movement Disorders; Nerve Net; Neural Pathways; Neuropsychological Tests; Parkinson Disease; Psychomotor Performance; Risk Factors

2013
Pisa syndrome in Parkinson's disease: an electrophysiological and imaging study.
    Journal of neurology, 2013, Volume: 260, Issue:8

    Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Atrophy; Dystonia; Electromyography; Female; Humans; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Paraspinal Muscles; Parkinson Disease; Posture; Radiography; Spine; Thorax

2013
Parkinsonian syndrome and ataxia as a presenting finding of acquired hepatocerebral degeneration.
    Metabolic brain disease, 2014, Volume: 29, Issue:1

    Topics: Antiparkinson Agents; Ataxia; Atrophy; Brain; Diagnosis, Differential; Female; Hepatic Encephalopathy; Humans; Levodopa; Liver Cirrhosis, Alcoholic; Magnetic Resonance Imaging; Middle Aged; Parkinsonian Disorders; Wine

2014
Association of homocysteine with ventricular dilatation and brain atrophy in Parkinson's disease.
    Movement disorders : official journal of the Movement Disorder Society, 2014, Volume: 29, Issue:3

    Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Atrophy; Brain; Dilatation; Female; Homocysteine; Humans; Levodopa; Male; Middle Aged; Parkinson Disease

2014
Asymmetrical leg atrophy in levodopa-responsive dystonia due to a novel GTP cyclohydrolase mutation.
    Movement disorders : official journal of the Movement Disorder Society, 2014, Volume: 29, Issue:3

    Topics: Adult; Atrophy; Dystonia; Genetic Predisposition to Disease; Genetic Testing; GTP Cyclohydrolase; Humans; Leg; Levodopa; Male; Mutation

2014
Dopa-responsive acute disseminated encephalomyelitis with marked atrophy of the striate body.
    BMJ case reports, 2016, Jun-02, Volume: 2016

    Topics: Adolescent; Antiparkinson Agents; Atrophy; Corpus Striatum; Encephalomyelitis, Acute Disseminated; Humans; Hypothermia; Levodopa; Magnetic Resonance Imaging; Male; Vomiting

2016
Levodopa-induced dyskinesias in spinocerebellar ataxia type 2.
    Archives of neurology, 2010, Volume: 67, Issue:1

    Topics: Antiparkinson Agents; Atrophy; Depressive Disorder; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Magnetic Resonance Imaging; Middle Aged; Parkinsonian Disorders; Rhombencephalon; Spinocerebellar Ataxias

2010
Hemiparkinsonism-hemiatrophy syndrome.
    Archives of Iranian medicine, 2011, Volume: 14, Issue:2

    Topics: Adult; Antiparkinson Agents; Atrophy; Benzothiazoles; Biperiden; Carbidopa; Cerebral Cortex; Cerebral Ventricles; Dopamine Agonists; Drug Combinations; Humans; Indans; Levodopa; Magnetic Resonance Imaging; Male; Monoamine Oxidase Inhibitors; Parkinson Disease, Secondary; Pramipexole; Tomography, X-Ray Computed

2011
Dopa-responsive parkinsonism phenotype of spinocerebellar ataxia type 2.
    Movement disorders : official journal of the Movement Disorder Society, 2002, Volume: 17, Issue:5

    Topics: Aged; Atrophy; Cerebellum; Corpus Striatum; Dopamine Agonists; Genotype; Humans; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Organotechnetium Compounds; Parkinsonian Disorders; Pedigree; Pons; Radiopharmaceuticals; Spinocerebellar Ataxias; Substantia Nigra; Tomography, Emission-Computed, Single-Photon; Tropanes

2002
Adverse effects of subthalamic nucleus DBS in a patient with multiple system atrophy.
    Neurology, 2003, Jul-22, Volume: 61, Issue:2

    Topics: Antiparkinson Agents; Atrophy; Carbidopa; Combined Modality Therapy; Contraindications; Deglutition Disorders; Diagnosis, Differential; Dysarthria; Electric Stimulation Therapy; Electrodes, Implanted; Female; Humans; Levodopa; Magnetic Resonance Imaging; Microelectrodes; Middle Aged; Multiple System Atrophy; Parkinson Disease; Pons; Putamen; Subthalamic Nucleus

2003
Spinocerebellar ataxia type 2 with Levodopa-responsive parkinsonism culminating in motor neuron disease.
    Movement disorders : official journal of the Movement Disorder Society, 2004, Volume: 19, Issue:7

    Topics: Alleles; Antiparkinson Agents; Atrophy; Brain Stem; Female; Humans; Levodopa; Magnetic Resonance Imaging; Middle Aged; Motor Neuron Disease; Parkinsonian Disorders; Pedigree; Phenotype; Spinocerebellar Ataxias

2004
Autopsy case of pure akinesia showing pallidonigro-luysian atrophy.
    Neuropathology : official journal of the Japanese Society of Neuropathology, 2005, Volume: 25, Issue:3

    Topics: Atrophy; Brain; Dopamine Agonists; Drug Resistance; Gait Apraxia; Humans; Immunohistochemistry; Levodopa; Male; Middle Aged; Neurodegenerative Diseases; Plaque, Amyloid

2005
Proximal myotonic dystrophy associated with parkinsonism.
    Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2006, Volume: 13, Issue:2

    Topics: Adult; Antiparkinson Agents; Atrophy; Electromyography; Female; Humans; Levodopa; Magnetic Resonance Imaging; Muscle Weakness; Myotonic Disorders; Parkinson Disease; Tomography, X-Ray Computed

2006
Effective treatment with levodopa and carbidopa for hypomyelination with atrophy of the basal ganglia and cerebellum.
    The Tohoku journal of experimental medicine, 2006, Volume: 209, Issue:2

    Topics: Administration, Oral; Antiparkinson Agents; Atrophy; Basal Ganglia; Carbidopa; Cerebellum; Child, Preschool; Demyelinating Diseases; Diagnosis, Differential; Drug Therapy, Combination; Dystonia; Fluorodeoxyglucose F18; Humans; Levodopa; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Spinocerebellar Degenerations; Treatment Outcome

2006
Cerebral folate deficiency and folinic acid treatment in hypomyelination with atrophy of the basal ganglia and cerebellum (H-ABC) syndrome.
    The Tohoku journal of experimental medicine, 2007, Volume: 211, Issue:1

    Topics: Antiparkinson Agents; Atrophy; Basal Ganglia; Brain Diseases, Metabolic; Carbidopa; Cerebellum; Demyelinating Diseases; Dystonia; Female; Folic Acid Deficiency; Humans; Leucovorin; Levodopa; Male; Syndrome; Tetrahydrofolates; Treatment Outcome; Vitamin B Complex

2007
Cerebral atrophy in Parkinson's disease patients with visual hallucinations.
    European journal of neurology, 2007, Volume: 14, Issue:7

    Topics: Antiparkinson Agents; Antipsychotic Agents; Atrophy; Cerebral Cortex; Female; Hallucinations; Humans; Levodopa; Magnetic Resonance Imaging; Male; Parietal Lobe; Parkinson Disease; Severity of Illness Index; Temporal Lobe; Visual Cortex; Visual Pathways

2007
[Effects of Maidang Rutong granule on l-dopa-induced galactozemia in rats].
    Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica, 2007, Volume: 32, Issue:8

    Topics: Animals; Animals, Newborn; Atrophy; Body Weight; Drug Combinations; Drugs, Chinese Herbal; Female; Lactation; Lactation Disorders; Levodopa; Male; Mammary Glands, Animal; Prolactin; Random Allocation; Rats; Rats, Sprague-Dawley

2007
The pharmacology of olivopontocerebellar atrophy.
    Advances in neurology, 1984, Volume: 41

    Topics: Adult; Amantadine; Atrophy; Baclofen; Brain Diseases; Carbidopa; Cerebellar Ataxia; Female; Humans; Levodopa; Male; Middle Aged; Olivary Nucleus; Pons; Propranolol; Syndrome

1984
Levodopa: long-term impact on Parkinson's disease.
    British medical journal (Clinical research ed.), 1981, Feb-07, Volume: 282, Issue:6262

    Topics: Atrophy; Cerebral Cortex; Dementia; Hallucinations; Humans; Levodopa; Parkinson Disease; Psychoses, Substance-Induced

1981
Progressive supranuclear palsy, computed tomography, and response to antiparkinsonian drugs.
    Neurology, 1981, Volume: 31, Issue:4

    Topics: Aged; Atrophy; Basal Ganglia Diseases; Benztropine; Cerebellum; Eye Movements; Humans; Levodopa; Male; Mesencephalon; Middle Aged; Parkinson Disease; Speech; Tomography, X-Ray Computed; Tropanes

1981
[L-dopa-resistant parkinsonism with cerebral atrophy: striato-nigral degeneration? 2 cases].
    Acta neurologica, 1981, Volume: 3, Issue:1

    Topics: Atrophy; Brain; Corpus Striatum; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Substantia Nigra

1981
[L-dopa-resistant Parkinson's disease with cerebral atrophy: striato-nigral degeneration?].
    Acta neurologica. Quaderni, 1981, Volume: 42

    Topics: Aromatic Amino Acid Decarboxylase Inhibitors; Atrophy; Brain Diseases; Corpus Striatum; Female; Humans; Levodopa; Male; Middle Aged; Nerve Degeneration; Parkinson Disease; Substantia Nigra

1981
A perplexing case of juvenile extrapyramidal disease.
    Italian journal of neurological sciences, 1981, Volume: 2, Issue:2

    Topics: Adolescent; Atrophy; Basal Ganglia Diseases; Bromocriptine; Electroencephalography; Female; Globus Pallidus; Humans; Levodopa; Parkinson Disease, Secondary; Tomography, X-Ray Computed

1981
Binswanger's disease presenting as levodopa-responsive parkinsonism: clinicopathologic study of three cases.
    Movement disorders : official journal of the Movement Disorder Society, 1995, Volume: 10, Issue:4

    Topics: Aged; Atrophy; Brain; Cerebral Arteries; Dementia, Multi-Infarct; Female; Humans; Intracranial Arteriosclerosis; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Supranuclear Palsy, Progressive

1995
Clinical/metabolic correlations in multiple system atrophy. A fludeoxyglucose F 18 positron emission tomographic study.
    Archives of neurology, 1995, Volume: 52, Issue:2

    Topics: Atrophy; Brain Diseases; Corpus Striatum; Deoxyglucose; Female; Fluorodeoxyglucose F18; Glucose; Humans; Levodopa; Male; Middle Aged; Olivopontocerebellar Atrophies; Parkinson Disease; Substantia Nigra; Tomography, Emission-Computed

1995
What is it? Case 1, 1993: parkinsonism, dysautonomia, and ophthalmoparesis.
    Movement disorders : official journal of the Movement Disorder Society, 1993, Volume: 8, Issue:4

    Topics: Atrophy; Autonomic Nervous System Diseases; Brain; Carbon Monoxide Poisoning; Deglutition Disorders; Diagnosis, Differential; Female; Humans; Levodopa; Middle Aged; Neurologic Examination; Ophthalmoplegia; Parkinson Disease

1993
[Parkinsonian features of Steele-Richardson-Olszewski syndrome].
    Revue neurologique, 1993, Volume: 149, Issue:1

    Topics: Aged; Atrophy; Brain Stem; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease, Secondary; Supranuclear Palsy, Progressive; Tomography, X-Ray Computed

1993
Dopa resistance in multiple-system atrophy: loss of postsynaptic D2 receptors.
    Annals of neurology, 1993, Volume: 34, Issue:2

    Topics: Aged; Atrophy; Autoradiography; Corpus Striatum; Drug Resistance; Female; Humans; Levodopa; Male; Parkinson Disease; Putamen; Receptors, Dopamine D1; Receptors, Dopamine D2; Synapses

1993
Whole blood monoamine oxidase activity in Parkinson's disease and multiple system atrophy patients.
    Journal of the neurological sciences, 1993, Volume: 117, Issue:1-2

    Topics: Aged; Aged, 80 and over; Atrophy; Basal Ganglia Diseases; Blood Platelets; Brain; Dopamine; Enzyme Induction; Female; Humans; Levodopa; Male; Middle Aged; Monoamine Oxidase; Olivopontocerebellar Atrophies; Parkinson Disease; Shy-Drager Syndrome

1993
Mitochondrial respiratory chain function in multiple system atrophy.
    Movement disorders : official journal of the Movement Disorder Society, 1997, Volume: 12, Issue:3

    Topics: Aged; Antiparkinson Agents; Atrophy; Blood Platelets; Brain; Citrate (si)-Synthase; Culture Techniques; Electron Transport; Humans; Levodopa; Middle Aged; Mitochondria; Nerve Degeneration; Parkinson Disease; Substantia Nigra

1997
Variations in axial, proximal, and distal motor response to L-dopa in multisystem atrophy and Parkinson's disease.
    Clinical neuropharmacology, 1997, Volume: 20, Issue:3

    Topics: Aged; Atrophy; Female; Gait; Humans; Levodopa; Male; Middle Aged; Motor Activity; Parkinson Disease

1997
Distinction of idiopathic Parkinson's disease from multiple-system atrophy by stimulation of growth-hormone release with clonidine.
    Lancet (London, England), 1997, Jun-28, Volume: 349, Issue:9069

    Topics: Adrenergic alpha-Agonists; Atrophy; Autonomic Nervous System Diseases; Clonidine; Diagnosis, Differential; Dopamine; Growth Hormone-Releasing Hormone; Human Growth Hormone; Humans; Levodopa; Middle Aged; Norepinephrine; Parkinson Disease

1997
Proton magnetic resonance spectroscopy in Parkinson's disease and atypical parkinsonian disorders.
    Movement disorders : official journal of the Movement Disorder Society, 1997, Volume: 12, Issue:6

    Topics: Aged; Antiparkinson Agents; Aspartic Acid; Atrophy; Cerebral Cortex; Choline; Corpus Striatum; Creatinine; Female; Globus Pallidus; Humans; Levodopa; Magnetic Resonance Spectroscopy; Middle Aged; Parkinson Disease; Parkinson Disease, Secondary; Phosphocreatine; Protons; Putamen; Supranuclear Palsy, Progressive

1997
Cerebral atrophy and long-term response to levodopa in Parkinson's disease.
    Journal of neurology, 1979, Volume: 222, Issue:1

    Topics: Adult; Aged; Atrophy; Brain; Cerebral Cortex; Cerebral Ventricles; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Prognosis; Time Factors; Tomography, X-Ray Computed

1979
The significance of cerebral atrophy for the symptomatology of Parkinson's disease.
    Journal of the neurological sciences, 1979, Volume: 42, Issue:2

    Topics: Adult; Aged; Atrophy; Brain; Cerebral Cortex; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Psychological Tests; Tomography, X-Ray Computed

1979
Hypothalamic atrophy.
    The Journal of clinical psychiatry, 1978, Volume: 39, Issue:4

    Topics: Adult; Atrophy; Brain Diseases; Cerebellum; Cerebral Ventricles; Humans; Hypertrophy; Hypothalamus; Levodopa; Male; Middle Aged; Pneumoencephalography; Receptors, Adrenergic; Receptors, Dopamine

1978
[Olivary-ponto-cerebellar atrophy with vegetative disorders treated with levodopa].
    Revista clinica espanola, 1977, Feb-28, Volume: 144, Issue:4

    Topics: Atrophy; Cerebellar Diseases; Humans; Levodopa; Male; Middle Aged; Olivary Nucleus; Pneumoencephalography; Pons

1977
Muscle stiffness and continuous electromyographic activity in old rats; an animal model for spasticity?
    Neuroscience, 1992, Volume: 51, Issue:1

    Topics: Aging; Animals; Atrophy; Baclofen; Benserazide; Drug Combinations; Electromyography; Female; Levodopa; Muscle Contraction; Muscle Denervation; Muscle Spasticity; Muscle Tonus; Muscles; Rats; Rats, Wistar

1992
The dopaminergic response in multiple system atrophy.
    Journal of neurology, neurosurgery, and psychiatry, 1992, Volume: 55, Issue:11

    Topics: Adult; Aged; Apomorphine; Atrophy; Brain Stem; Female; Humans; Injections, Subcutaneous; Levodopa; Male; Middle Aged; Motor Skills; Parkinson Disease; Terminology as Topic

1992
[A case at Salpêtrière hospital November 1990. Parkinson syndrome with poor response to dopa therapy in a 64 year-old man].
    Revue neurologique, 1992, Volume: 148, Issue:8-9

    Topics: Atrophy; Corpus Striatum; Diagnosis, Differential; Drug Resistance; Humans; Levodopa; Male; Middle Aged; Olivopontocerebellar Atrophies; Parkinson Disease, Secondary; Substantia Nigra; Supranuclear Palsy, Progressive

1992
Hemiballism and chorea in a patient with parkinsonism due to a multisystem degeneration.
    Movement disorders : official journal of the Movement Disorder Society, 1992, Volume: 7, Issue:1

    Topics: Aged; Antiparkinson Agents; Atrophy; Brain; Carbidopa; Central Nervous System Diseases; Chorea; Diagnosis, Differential; Drug Combinations; Female; Humans; Levodopa; Movement Disorders; Nerve Degeneration; Parkinson Disease; Spinal Cord

1992
Relationship between levodopa-independent symptoms and central atrophy evaluated by magnetic resonance imaging in Parkinson's disease.
    European neurology, 1992, Volume: 32, Issue:1

    Topics: Aged; Atrophy; Female; Frontal Lobe; Humans; Levodopa; Magnetic Resonance Imaging; Male; Neurologic Examination; Parkinson Disease

1992
Delayed cyanide induced dystonia.
    Journal of neurology, neurosurgery, and psychiatry, 1992, Volume: 55, Issue:3

    Topics: Adolescent; Adult; Apomorphine; Atrophy; Brain Damage, Chronic; Cerebral Cortex; Dystonia; Electroencephalography; Follow-Up Studies; Humans; Levodopa; Male; Neurologic Examination; Potassium Cyanide; Putamen; Reaction Time

1992
The diagnosis of multiple system atrophy.
    Annals of neurology, 1991, Volume: 29, Issue:6

    Topics: Atrophy; Autonomic Nervous System Diseases; Cerebellar Diseases; Diagnosis, Differential; Humans; Levodopa; Muscle Rigidity

1991
Hemiparkinsonism-hemiatrophy syndrome: clinical and neuroradiologic features.
    Neurology, 1990, Volume: 40, Issue:11

    Topics: Adolescent; Adult; Atrophy; Brain; Extremities; Female; Follow-Up Studies; Humans; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Parkinson Disease, Secondary; Retrospective Studies; Syndrome; Tomography, X-Ray Computed

1990
Dopamine agonists suppress visual-cortical reflex myoclonus.
    Journal of neurology, neurosurgery, and psychiatry, 1985, Volume: 48, Issue:12

    Topics: Aged; Apomorphine; Atrophy; Carbidopa; Cerebellum; Drug Therapy, Combination; Electromyography; Epilepsies, Myoclonic; Ergolines; Evoked Potentials, Somatosensory; Evoked Potentials, Visual; Female; Humans; Levodopa; Lisuride; Olivary Nucleus; Photic Stimulation; Pons; Reflex; Visual Cortex

1985